IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PILOTTO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.310
AS - Asia 6.523
EU - Europa 4.381
SA - Sud America 1.512
Continente sconosciuto - Info sul continente non disponibili 311
AF - Africa 161
OC - Oceania 11
Totale 26.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.778
SG - Singapore 2.425
CN - Cina 1.662
IT - Italia 1.259
BR - Brasile 1.230
HK - Hong Kong 730
DE - Germania 590
FR - Francia 525
BD - Bangladesh 523
VN - Vietnam 434
UA - Ucraina 414
GB - Regno Unito 374
FI - Finlandia 306
CA - Canada 289
RU - Federazione Russa 225
TR - Turchia 196
IE - Irlanda 174
IN - India 159
MX - Messico 94
NL - Olanda 91
AR - Argentina 88
PL - Polonia 84
ES - Italia 70
CZ - Repubblica Ceca 58
ID - Indonesia 55
JP - Giappone 55
SE - Svezia 53
ZA - Sudafrica 53
CO - Colombia 51
AT - Austria 50
IQ - Iraq 47
EC - Ecuador 42
VE - Venezuela 34
SA - Arabia Saudita 33
CR - Costa Rica 29
PK - Pakistan 29
JM - Giamaica 25
MA - Marocco 23
EG - Egitto 21
BE - Belgio 20
UZ - Uzbekistan 18
PH - Filippine 17
CL - Cile 16
KE - Kenya 16
PY - Paraguay 16
TT - Trinidad e Tobago 15
AE - Emirati Arabi Uniti 14
LT - Lituania 14
IL - Israele 13
JO - Giordania 13
KZ - Kazakistan 12
NP - Nepal 12
AZ - Azerbaigian 11
GT - Guatemala 11
PE - Perù 11
HN - Honduras 10
PT - Portogallo 10
AL - Albania 9
AU - Australia 9
BO - Bolivia 9
CH - Svizzera 9
MY - Malesia 9
NG - Nigeria 9
PA - Panama 9
UY - Uruguay 9
DZ - Algeria 8
SV - El Salvador 8
TH - Thailandia 8
DO - Repubblica Dominicana 7
LB - Libano 7
NI - Nicaragua 7
PR - Porto Rico 7
BB - Barbados 6
DK - Danimarca 6
IR - Iran 6
RO - Romania 6
SN - Senegal 6
ET - Etiopia 5
GY - Guiana 5
OM - Oman 5
PS - Palestinian Territory 5
RS - Serbia 5
TN - Tunisia 5
TW - Taiwan 5
BS - Bahamas 4
EE - Estonia 4
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
GR - Grecia 3
HR - Croazia 3
KR - Corea 3
MD - Moldavia 3
AM - Armenia 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
Totale 25.866
Salva come PNG Salva come JPEG
Città #
Ashburn 1.404
Singapore 1.304
Fairfield 884
San Jose 771
Hong Kong 725
Woodbridge 578
New York 496
Council Bluffs 458
Los Angeles 427
Houston 426
Seattle 402
The Dalles 372
Beijing 347
Dallas 336
Cambridge 330
Jacksonville 323
Wilmington 299
Ann Arbor 262
Princeton 238
Helsinki 205
Lauterbourg 193
Milan 193
Chandler 189
Santa Clara 175
Chicago 172
Istanbul 170
Ho Chi Minh City 158
Dublin 153
Munich 151
Buffalo 148
Columbus 122
San Francisco 119
São Paulo 104
Des Moines 103
Brescia 101
Dearborn 97
Nanjing 94
Denver 89
Atlanta 88
Redondo Beach 88
Hanoi 86
London 84
Phoenix 84
Montreal 82
Warsaw 80
Rome 79
San Diego 79
Orem 76
Moscow 74
Toronto 74
Brooklyn 67
Nuremberg 63
North Bergen 61
Turku 57
Shanghai 56
Frankfurt am Main 53
Boston 50
Shenyang 50
Chennai 49
Salt Lake City 45
Changsha 44
Tokyo 42
Guangzhou 38
Nanchang 37
Tampa 37
Stockholm 35
Mexico City 34
Rio de Janeiro 34
Brno 33
Belo Horizonte 32
Naples 30
Boardman 29
Lappeenranta 29
Lancaster 28
Brasília 27
Charlotte 27
Madrid 27
Jinan 26
Tianjin 26
Vienna 26
Manchester 25
Florence 24
Johannesburg 24
Washington 24
Amsterdam 23
Hangzhou 23
Ningbo 23
Turin 23
Carrboro 22
Da Nang 22
Hebei 21
Las Vegas 21
Miami 21
Philadelphia 21
Romola 21
Verona 21
Elk Grove Village 20
Norwalk 20
Olomouc 20
San José 20
Totale 15.723
Salva come PNG Salva come JPEG
Nome #
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 1.734
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 380
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 369
COVID-19 impact on consecutive neurological patients admitted to the emergency department 273
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 257
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 250
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 239
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 230
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 212
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 206
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 205
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 204
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 203
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 201
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 193
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 191
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 187
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 185
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 184
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 179
Vascular risk factors and cognition in Parkinson's disease 178
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 175
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 175
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 173
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 170
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 168
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 168
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 164
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 162
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 162
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 160
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 160
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 158
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 158
Long-term neurological outcome in patients presenting with encephalitis 158
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 157
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 153
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 152
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 147
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 147
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 146
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 144
Central serous chorioretinopathy: Pathogenesis and management 144
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 143
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 142
Dopaminergic deficits along the spectrum of Alzheimer’s disease 141
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 141
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 140
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 140
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 140
Disease-modifying therapies in frontotemporal lobar degeneration. 139
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 138
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 137
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 137
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 137
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 137
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 135
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 135
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 134
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 133
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 133
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 132
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 132
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 131
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 131
Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease 131
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 130
Family History in Parkinson's Disease: A National Cross-Sectional Study 129
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 129
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 125
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 125
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 125
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 125
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 125
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 125
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 124
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 123
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 123
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 122
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 122
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 121
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 120
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 120
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 119
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 118
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 118
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 117
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 116
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 116
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 115
Metabolic patterns across core features in dementia with lewy bodies 115
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 115
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 113
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 113
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 113
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 112
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay 112
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 112
Occipital atrophy signature in prodromal Lewy bodies disease 111
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 111
Totale 16.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022738 0 0 0 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20269.392 794 1.114 724 1.234 720 631 1.267 505 597 769 634 403
2026/20274.526 2.070 458 656 1.342 0 0 0 0 0 0 0 0
Totale 26.209